Literature DB >> 11147095

Mendelian inheritance in Germany between 1900 and 1910. The case of Carl Correns (1864-1933).

H J Rheinberger1.   

Abstract

Carl Correns (1864-1933) came to recognize Mendel's rules between 1894 and 1900 while trying to find out the mechanism of xenia, that is, the direct influence of the fertilizing pollen on the mother plant in maize and peas among other species. In this paper, I am concerned with the ten years of Correns' work after the annus mirabilis of 1900 until 1910, when the main outlines of the new science of genetics had been established. It is generally assumed that after 1900 Correns quickly began probing the limits of Mendelian inheritance, both as far as the explanatory force of formal transmission genetics and the generality of Mendel's laws are concerned. A careful examination of his papers however shows that he was much more interested in the scope of Mendelian inheritance than in its limits. Even his work with variegated Mirabilis plants, which historiographical folklore still presents as a result of Correns' growing interest in cytoplasmic inheritance, can be shown to have been conducted to corroborate just the opposite, namely, the validity of the nuclear paradigm. The paper will show that Correns' research results in those years (among them the Mendelian inheritance of sex in higher plants) were the outcome of a complex experimental program which involved breeding experiments with dozens of different species.

Entities:  

Mesh:

Year:  2000        PMID: 11147095     DOI: 10.1016/s0764-4469(00)01267-1

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  2 in total

1.  Muriel Wheldale Onslow and early biochemical genetics.

Authors:  Marsha L Richmond
Journal:  J Hist Biol       Date:  2007       Impact factor: 1.326

Review 2.  The contributions of Nettie Stevens to the field of sex chromosome biology.

Authors:  Sarah B Carey; Laramie Aközbek; Alex Harkess
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-03-21       Impact factor: 6.237

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.